- Home
- RAPP vs DEA Comparison
RAPP vs DEA Comparison
Compare RAPP & DEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RAPP | DEA |
|---|---|---|
| Founded | 2022 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Real Estate Investment Trusts |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2024 | 2015 |
Fundamental Metrics
Financial Performance| Metric | RAPP | DEA |
|---|---|---|
| Price | $27.16 | $24.18 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 6 |
| Target Price | ★ $47.00 | $24.99 |
| AVG Volume (30 Days) | 337.3K | ★ 421.7K |
| Earning Date | 03-10-2026 | 02-23-2026 |
| Dividend Yield | N/A | ★ 7.45% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.30 |
| Revenue | N/A | ★ $334,212,000.00 |
| Revenue This Year | N/A | $9.60 |
| Revenue Next Year | N/A | $8.24 |
| P/E Ratio | ★ N/A | $81.20 |
| Revenue Growth | N/A | ★ 10.62 |
| 52 Week Low | $6.43 | $19.33 |
| 52 Week High | $42.27 | $29.49 |
Technical Indicators
Market Signals| Indicator | RAPP | DEA |
|---|---|---|
| Relative Strength Index (RSI) | 48.33 | 68.44 |
| Support Level | $25.21 | $23.00 |
| Resistance Level | $28.59 | $23.44 |
| Average True Range (ATR) | 1.53 | 0.52 |
| MACD | 0.01 | 0.09 |
| Stochastic Oscillator | 52.96 | 100.00 |
Price Performance
Historical ComparisonAbout RAPP Rapport Therapeutics Inc.
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.
About DEA Easterly Government Properties Inc.
Easterly Government Properties Inc is a real estate investment trust. It is engaged in the acquisition, development, and management of Class A commercial properties that are leased to U.S. government agencies. The company generates all its revenue by leasing its properties to such agencies.